These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6633506)

  • 1. Structure-activity relationships of cholinesterase inhibitors. I. Quantum mechanical study of affinities of phenyl N-methyl carbamates.
    Goldblum A
    Mol Pharmacol; 1983 Nov; 24(3):436-42. PubMed ID: 6633506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular recognition by cholesterol esterase of active site ligands: structure-reactivity effects for inhibition by aryl carbamates and subsequent carbamylenzyme turnover.
    Feaster SR; Lee K; Baker N; Hui DY; Quinn DM
    Biochemistry; 1996 Dec; 35(51):16723-34. PubMed ID: 8988009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
    Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
    J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
    Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
    Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the peripheral anionic site of acetylcholinesterase with quantitative structure activity relationships for inhibition by biphenyl-4-acyoxylate-4'-N-Butylcarbamates.
    Lin G; Chen GH; Yeh SC; Lu CP
    J Biochem Mol Toxicol; 2005; 19(4):234-43. PubMed ID: 16173062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical studies of the binding of trifluoperazine derivatives to site (82-93) of calmodulin: effect of lengthenings of the methylene linker chain on the binding affinity.
    Gresh N
    Mol Pharmacol; 1987 Jun; 31(6):617-22. PubMed ID: 3600606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction path potential for complex systems derived from combined ab initio quantum mechanical and molecular mechanical calculations.
    Lu Z; Yang W
    J Chem Phys; 2004 Jul; 121(1):89-100. PubMed ID: 15260525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.
    Myllymäki MJ; Käsnänen H; Kataja AO; Lahtela-Kakkonen M; Saario SM; Poso A; Koskinen AM
    Eur J Med Chem; 2009 Oct; 44(10):4179-91. PubMed ID: 19539407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819).
    Bartolucci C; Siotto M; Ghidini E; Amari G; Bolzoni PT; Racchi M; Villetti G; Delcanale M; Lamba D
    J Med Chem; 2006 Aug; 49(17):5051-8. PubMed ID: 16913695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental/theoretical electrostatic properties of a styrylquinoline-type HIV-1 integrase inhibitor and its progenitors.
    Firley D; Courcot B; Gillet JM; Fraisse B; Zouhiri F; Desmaële D; d'Angelo J; Ghermani NE
    J Phys Chem B; 2006 Jan; 110(1):537-47. PubMed ID: 16471566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and molluscicidal structure-activity relationships of some novel 1,2,4-triazole N-methyl carbamates.
    Radwan MA; el-Zemity SR
    Pest Manag Sci; 2001 Aug; 57(8):707-12. PubMed ID: 11517724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of graph theory and quantum chemistry for structure-activity relationships.
    Balasubramanian K
    SAR QSAR Environ Res; 1994; 2(1-2):59-77. PubMed ID: 8790640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QMQSAR: utilization of a semiempirical probe potential in a field-based QSAR method.
    Dixon S; Merz KM; Lauri G; Ianni JC
    J Comput Chem; 2005 Jan; 26(1):23-34. PubMed ID: 15526326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DFT-based QSARs study of protoporphyrinogen oxidase inhibitors: phenyl triazolinones.
    Zhang L; Wan J; Yang G
    Bioorg Med Chem; 2004 Dec; 12(23):6183-91. PubMed ID: 15519162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors.
    Chaudhaery SS; Roy KK; Saxena AK
    J Chem Inf Model; 2009 Jun; 49(6):1590-601. PubMed ID: 19441865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives.
    Piazzi L; Cavalli A; Belluti F; Bisi A; Gobbi S; Rizzo S; Bartolini M; Andrisano V; Recanatini M; Rampa A
    J Med Chem; 2007 Aug; 50(17):4250-4. PubMed ID: 17655212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new force field (ECEPP-05) for peptides, proteins, and organic molecules.
    Arnautova YA; Jagielska A; Scheraga HA
    J Phys Chem B; 2006 Mar; 110(10):5025-44. PubMed ID: 16526746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.